Interaction of secobarbital with warfarin pseudoracemates

Area of Science:

• Pharmacology
• Drug Metabolism
• Clinical Pharmacology

Background:

• Warfarin is a widely prescribed anticoagulant.
• Understanding drug interactions is crucial for patient safety.
• Secobarbital is a sedative-hypnotic drug.

Purpose of the Study:

• To investigate the interaction between secobarbital and warfarin.
• To determine how secobarbital affects warfarin's hypoprothrombinemic effect.
• To analyze the impact on warfarin enantiomer clearance.

Main Methods:

• Synthesis of a 13C-labeled warfarin pseudoracemate.
• Administration of warfarin with and without secobarbital to healthy subjects.
• Analysis of plasma warfarin levels and prothrombin activity.
• Enantiomeric ratio determination using mass spectrometry.

Main Results:

• Secobarbital significantly reduced warfarin's hypoprothrombinemic effect.
• Plasma clearance of both R-warfarin and S-warfarin enantiomers increased with secobarbital.
• The effect was observed for both the more and less hypoprothrombinemic warfarin enantiomers.

Conclusions:

• Secobarbital diminishes warfarin's anticoagulant effect.
• This interaction is mediated by increased plasma clearance of both warfarin enantiomers.
• Clinicians should consider this interaction when co-prescribing secobarbital and warfarin.